SCHEMBL11517217

SCHEMBL11517217

CC(C)C(=O)CCCCC(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.58
TSHR P16473 5/20 0.55
NFKB1 P19838 1/20 0.55
PMP22 Q01453 1/20 0.55
AKR1B1 P15121 1/20 0.52
GPR84 Q9NQS5 8/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
HDAC11 Q96DB2 5/20 0.50
PTPN1 P18031 3/20 0.50
ALDH1A1 P00352 2/20 0.50
SLC22A6 Q4U2R8 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
FFAR1 O14842 2/20 0.50
FFAR4 Q5NUL3 2/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11518579 0.97 TSHR (0.60) LMNATSHRNFKB1PMP22AKR1B1
SCHEMBL26428802 0.97 TSHR (0.60) LMNATSHRNFKB1PMP22AKR1B1
SCHEMBL22223310 0.97 TSHR (0.60) LMNATSHRNFKB1PMP22AKR1B1
SCHEMBL27050808 0.97 TSHR (0.60) LMNATSHRNFKB1PMP22AKR1B1
SCHEMBL11518693 0.97 TSHR (0.60) LMNATSHRNFKB1PMP22AKR1B1
SCHEMBL13176551 0.97 TSHR (0.60) LMNATSHRNFKB1PMP22AKR1B1
SCHEMBL25834780 0.97 TSHR (0.60) LMNATSHRNFKB1PMP22AKR1B1
SCHEMBL10299251 0.95 SLC22A6 (0.58) LMNATSHRNFKB1PMP22AKR1B1
SCHEMBL17992598 0.89 CES2 (0.44) LMNAMEN1KMT2A
SCHEMBL9973392 0.86 CES2 (0.48) LMNATSHRNFKB1PMP22MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022034927-A1 AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS 国立大学法人東京大学 2022-02-17 WO disclosed
WO-2022034928-A1 AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS 日産化学株式会社 2022-02-17 WO disclosed
US-20180186755-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA INC (US) 2018-07-05 US disclosed
US-20170363637-A1 Method and Kit for Determining Risk of Preterm Birth and/or Birth of Low-Birth-Weight Baby HIROSHIMA UNIVERSITY (JP) 2017-12-21 US disclosed
US-9683093-B1 Resin composition and resin molded article FUJI XEROX CO., LTD. (JP) 2017-06-20 US disclosed
US-7737287-B2 Anomeric derivatives of monosaccharides ALCHEMIA LIMITED (AU) 2010-06-15 US disclosed
US-4154851-A ANTIDEPRESSANTS, ANTIAGRESSIVE AGENTS SCIENCE UNION ET CIE, SOCIETE FRANCAISE DE RECHERCHE MEDICALE (FR) 1979-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170363637-A1 Method and Kit for Determining Risk of Preterm Birth and/or Birth of Low-Birth-Weight Baby LGALS3, LGALS3BP, LGALS1 LMNA 144/4885TSHR 2759/4885NFKB1 1365/4885
US-20180186755-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF LOXL2, LOXL1, LOX LMNA 179/4885TSHR 4552/4885NFKB1 3235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.